Inqovi (decitabine and cedazuridine) has received approval for at-home treatment of adult patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
